X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-23 | IMVT | Stout Jay S | CTO | S - Sale | $14.79 | -1,925 | 209,243 | -1% | -$28,471 | ||||||
2025-04-23 | IMVT | Geffner Michael | Chief Medical Officer | S - Sale | $14.79 | -2,349 | 225,370 | -1% | -$34,742 | ||||||
2025-04-16 | IMVT | Barnett Eva Renee | CFO | S - Sale | $14.89 | -2,993 | 396,774 | -1% | -$44,566 | ||||||
2025-04-16 | IMVT | Salzmann Peter | CEO | S - Sale | $14.89 | -8,321 | 1,178,191 | -1% | -$123,900 | ||||||
2025-04-09 | IMVT | Salzmann Peter | CEO | S - Sale | $12.99 | -28,094 | 1,186,512 | -2% | -$364,941 | ||||||
2025-03-07 | IMVT | Fromkin Andrew J. | Dir | S - Sale | $19.60 | -8,000 | 91,913 | -8% | -$156,769 | ||||||
2025-02-19 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $20.86 | -2,055 | 357,353 | -1% | -$42,867 | ||||||
2025-02-19 | IMVT | Barnett Eva Renee | CFO | S - Sale | $20.86 | -2,814 | 321,952 | -1% | -$58,700 | ||||||
2025-02-19 | IMVT | Salzmann Peter | CEO | S - Sale | $20.86 | -15,439 | 948,786 | -2% | -$322,058 | ||||||
2025-01-22 | IMVT | Stout Jay S | CTO | S - Sale | $23.59 | -2,195 | 139,991 | -2% | -$51,780 | ||||||
2025-01-22 | IMVT | Geffner Michael | Chief Medical Officer | S - Sale | $23.59 | -2,657 | 132,314 | -2% | -$62,679 | ||||||
2025-01-15 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $23.83 | -2,383 | 359,408 | -1% | -$56,782 | ||||||
2025-01-15 | IMVT | Barnett Eva Renee | CFO | S - Sale | $23.83 | -2,298 | 324,766 | -1% | -$54,757 | ||||||
2025-01-15 | IMVT | Salzmann Peter | CEO | S - Sale | $23.83 | -8,767 | 964,225 | -1% | -$208,900 | ||||||
2025-01-13 | IMVT | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $20.00 | +16,845,010 | 96,650,341 | +21% | +$336,900,200 | ||||||
2025-01-08 | IMVT | Barnett Eva Renee | CFO | S - Sale | $24.10 | -4,105 | 327,064 | -1% | -$98,931 | ||||||
2025-01-08 | IMVT | Salzmann Peter | CEO | S - Sale | $24.10 | -5,105 | 972,992 | -1% | -$123,031 | ||||||
2024-12-02 | IMVT | Pande Atul | Dir | S - Sale | $28.54 | -7,750 | 106,663 | -7% | -$221,185 | ||||||
2024-12-02 | IMVT | Hughes Douglas J. | Dir | S - Sale | $28.54 | -5,425 | 119,585 | -4% | -$154,830 | ||||||
2024-11-20 | IMVT | Levine Mark S. | GC | S - Sale | $25.45 | -3,650 | 319,228 | -1% | -$92,893 | ||||||
2024-11-20 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $25.45 | -3,353 | 361,791 | -1% | -$85,334 | ||||||
2024-11-20 | IMVT | Barnett Eva Renee | CFO | S - Sale | $25.45 | -4,174 | 331,169 | -1% | -$106,228 | ||||||
2024-11-20 | IMVT | Salzmann Peter | CEO | S - Sale | $25.45 | -16,692 | 978,097 | -2% | -$424,811 | ||||||
2024-10-23 | IMVT | Levine Mark S. | GC | S - Sale | $29.53 | -4,361 | 322,878 | -1% | -$128,780 | ||||||
2024-10-23 | IMVT | Geffner Michael | Chief Medical Officer | S - Sale | $29.53 | -3,189 | 134,971 | -2% | -$94,171 | ||||||
2024-10-23 | IMVT | Stout Jay S | CTO | S - Sale | $29.53 | -2,740 | 142,186 | -2% | -$80,912 | ||||||
2024-10-16 | IMVT | Salzmann Peter | CEO | S - Sale | $28.79 | -9,095 | 994,789 | -1% | -$261,845 | ||||||
2024-10-16 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $28.79 | -3,188 | 365,144 | -1% | -$91,783 | ||||||
2024-10-16 | IMVT | Levine Mark S. | GC | S - Sale | $28.79 | -2,860 | 327,239 | -1% | -$82,339 | ||||||
2024-10-16 | IMVT | Barnett Eva Renee | CFO | S - Sale | $28.79 | -3,271 | 335,343 | -1% | -$94,172 | ||||||
2024-10-09 | IMVT | Barnett Eva Renee | CFO | S - Sale | $29.56 | -5,162 | 338,614 | -2% | -$152,589 | ||||||
2024-10-09 | IMVT | Salzmann Peter | CEO | S - Sale | $29.56 | -4,460 | 1,003,884 | 0% | -$131,838 | ||||||
2024-08-21 | IMVT | Levine Mark S. | GC | S - Sale | $31.86 | -3,295 | 330,099 | -1% | -$104,976 | ||||||
2024-08-21 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $31.86 | -3,027 | 368,332 | -1% | -$96,437 | ||||||
2024-08-21 | IMVT | Barnett Eva Renee | CFO | S - Sale | $31.86 | -3,768 | 343,776 | -1% | -$120,045 | ||||||
2024-08-21 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $31.86 | -3,027 | 440,959 | -1% | -$96,437 | ||||||
2024-08-21 | IMVT | Salzmann Peter | CEO | S - Sale | $31.86 | -15,068 | 1,008,344 | -1% | -$480,052 | ||||||
2024-07-24 | IMVT | Stout Jay S | CTO | S - Sale | $27.76 | -2,813 | 144,926 | -2% | -$78,089 | ||||||
2024-07-24 | IMVT | Geffner Michael | Chief Medical Officer | S - Sale | $27.76 | -3,456 | 138,160 | -2% | -$95,939 | ||||||
2024-07-24 | IMVT | Levine Mark S. | GC | S - Sale | $27.76 | -4,015 | 333,394 | -1% | -$111,456 | ||||||
2024-07-17 | IMVT | Levine Mark S. | GC | S - Sale | $29.69 | -2,505 | 337,409 | -1% | -$74,382 | ||||||
2024-07-17 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $29.69 | -3,044 | 371,359 | -1% | -$90,386 | ||||||
2024-07-17 | IMVT | Barnett Eva Renee | CFO | S - Sale | $29.69 | -3,123 | 347,544 | -1% | -$92,733 | ||||||
2024-07-17 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $29.69 | -2,867 | 443,986 | -1% | -$85,132 | ||||||
2024-07-17 | IMVT | Salzmann Peter | CEO | S - Sale | $29.69 | -8,685 | 1,023,412 | -1% | -$257,888 | ||||||
2024-07-09 | IMVT | Barnett Eva Renee | CFO | S - Sale | $28.06 | -4,747 | 350,667 | -1% | -$133,201 | ||||||
2024-07-09 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $28.06 | -1,527 | 446,853 | 0% | -$42,848 | ||||||
2024-07-09 | IMVT | Salzmann Peter | CEO | S - Sale | $28.06 | -4,619 | 1,032,097 | 0% | -$129,609 | ||||||
2024-05-22 | IMVT | Barnett Eva Renee | CFO | S - Sale | $29.65 | -4,042 | 355,414 | -1% | -$119,845 | ||||||
2024-05-22 | IMVT | Salzmann Peter | CEO | S - Sale | $29.65 | -16,163 | 1,036,716 | -2% | -$479,233 | ||||||
2024-05-22 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $29.65 | -3,247 | 448,380 | -1% | -$96,274 | ||||||
2024-05-22 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $29.65 | -3,247 | 374,403 | -1% | -$96,274 | ||||||
2024-05-22 | IMVT | Levine Mark S. | GC | S - Sale | $29.65 | -3,242 | 339,914 | -1% | -$96,125 | ||||||
2024-04-24 | IMVT | Geffner Michael | Chief Medical Officer | S - Sale | $28.90 | -3,261 | 141,616 | -2% | -$94,243 | ||||||
2024-04-24 | IMVT | Stout Jay S | CTO | S - Sale | $28.90 | -7,239 | 147,739 | -5% | -$209,207 | ||||||
2024-04-24 | IMVT | Levine Mark S. | GC | S - Sale | $28.90 | -3,963 | 343,156 | -1% | -$114,531 | ||||||
2024-04-17 | IMVT | Levine Mark S. | GC | S - Sale | $29.06 | -9,827 | 347,119 | -3% | -$285,554 | ||||||
2024-04-17 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $29.06 | -8,280 | 377,650 | -2% | -$240,602 | ||||||
2024-04-17 | IMVT | Barnett Eva Renee | CFO | S - Sale | $29.06 | -12,253 | 359,456 | -3% | -$356,049 | ||||||
2024-04-17 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $29.06 | -10,115 | 451,627 | -2% | -$293,923 | ||||||
2024-04-17 | IMVT | Salzmann Peter | CEO | S - Sale | $29.06 | -34,079 | 1,052,879 | -3% | -$990,269 | ||||||
2024-04-09 | IMVT | Barnett Eva Renee | CFO | S - Sale | $31.18 | -3,689 | 371,709 | -1% | -$115,023 | ||||||
2024-04-09 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $31.18 | -1,053 | 461,742 | 0% | -$32,833 | ||||||
2024-04-09 | IMVT | Salzmann Peter | CEO | S - Sale | $31.18 | -4,807 | 1,086,958 | 0% | -$149,882 | ||||||
2024-02-22 | IMVT | Barnett Eva Renee | CFO | S - Sale | $36.15 | -2,930 | 320,420 | -1% | -$105,920 | ||||||
2024-02-22 | IMVT | Levine Mark S. | GC | S - Sale | $36.15 | -2,134 | 301,968 | -1% | -$77,144 | ||||||
2024-02-22 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $36.15 | -2,221 | 330,952 | -1% | -$80,289 | ||||||
2024-02-22 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $36.15 | -2,146 | 407,817 | -1% | -$77,578 | ||||||
2024-02-22 | IMVT | Salzmann Peter | CEO | S - Sale | $36.15 | -13,454 | 931,231 | -1% | -$486,362 | ||||||
2024-01-26 | IMVT | Levine Mark S. | GC | S - Sale | $37.92 | -3,027 | 304,102 | -1% | -$114,778 | ||||||
2024-01-26 | IMVT | Geffner Michael | Chief Medical Officer | S - Sale | $37.92 | -10,101 | 89,899 | -10% | -$383,012 | ||||||
2024-01-18 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $41.03 | -424 | 333,173 | 0% | -$17,397 | ||||||
2024-01-11 | IMVT | Barnett Eva Renee | CFO | S - Sale | $41.83 | -3,515 | 323,350 | -1% | -$147,023 | ||||||
2024-01-05 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $38.59 | -1,297 | 409,963 | 0% | -$50,051 | ||||||
2024-01-05 | IMVT | Salzmann Peter | CEO | S - Sale | $38.59 | -3,824 | 944,685 | 0% | -$147,568 | ||||||
2023-12-01 | IMVT | Fromkin Andrew J. | Dir | S - Sale | $39.73 | -12,350 | 88,658 | -12% | -$490,697 | ||||||
2023-12-01 | IMVT | Pande Atul | Dir | S - Sale | $39.73 | -12,350 | 103,158 | -11% | -$490,668 | ||||||
2023-12-01 | IMVT | Migausky George V | Dir | S - Sale | $39.73 | -12,700 | 109,808 | -10% | -$504,567 | ||||||
2023-11-22 | IMVT | Salzmann Peter | CEO | S - Sale | $32.78 | -16,217 | 948,509 | -2% | -$531,581 | ||||||
2023-11-22 | IMVT | Barnett Eva Renee | CFO | S - Sale | $32.78 | -4,055 | 326,865 | -1% | -$132,920 | ||||||
2023-11-22 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $32.78 | -3,265 | 411,260 | -1% | -$107,024 | ||||||
2023-11-22 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $32.78 | -3,265 | 333,597 | -1% | -$107,024 | ||||||
2023-11-22 | IMVT | Levine Mark S. | GC | S - Sale | $32.78 | -3,252 | 307,129 | -1% | -$106,598 | ||||||
2023-10-25 | IMVT | Levine Mark S. | GC | S - Sale | $34.66 | -4,107 | 310,381 | -1% | -$142,349 | ||||||
2023-10-19 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $36.80 | -530 | 336,862 | 0% | -$19,504 | ||||||
2023-10-10 | IMVT | Barnett Eva Renee | CFO | S - Sale | $36.92 | -4,557 | 330,920 | -1% | -$168,244 | ||||||
2023-10-05 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $36.25 | -1,735 | 414,525 | 0% | -$62,885 | ||||||
2023-10-05 | IMVT | Salzmann Peter | CEO | S - Sale | $36.25 | -5,239 | 964,726 | -1% | -$189,887 | ||||||
2023-10-02 | IMVT | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $38.00 | +1,526,316 | 79,805,331 | +2% | +$58,000,008 | ||||||
2023-08-30 | IMVT | Salzmann Peter | CEO | S - Sale | $22.02 | -56,774 | 969,965 | -6% | -$1,250,338 | ||||||
2023-08-24 | IMVT | Levine Mark S. | GC | S - Sale | $20.30 | -12,286 | 314,488 | -4% | -$249,406 | ||||||
2023-08-24 | IMVT | Barnett Eva Renee | CFO | S - Sale | $20.30 | -14,386 | 335,477 | -4% | -$292,036 | ||||||
2023-08-24 | IMVT | Butchko Julia G. | Chief Development Officer | S - Sale | $20.30 | -12,333 | 416,260 | -3% | -$250,360 | ||||||
2023-08-24 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $20.30 | -12,333 | 337,392 | -4% | -$250,360 | ||||||
2023-08-14 | IMVT | Salzmann Peter | CEO | S - Sale | $21.42 | -103,058 | 1,026,739 | -9% | -$2,207,178 | ||||||
2023-08-07 | IMVT | Salzmann Peter | CEO | S - Sale | $21.73 | -101,339 | 1,129,797 | -8% | -$2,202,096 | ||||||
2023-07-26 | IMVT | Levine Mark S. | GC | S - Sale | $21.63 | -3,917 | 326,774 | -1% | -$84,725 | ||||||
2023-07-19 | IMVT | Macias William L. | Chief Medical Officer | S - Sale | $24.94 | -426 | 349,725 | 0% | -$10,624 | ||||||
2023-07-19 | IMVT | Barnett Eva Renee | CFO | S - Sale | $24.94 | -2,725 | 349,863 | -1% | -$67,962 | ||||||
2023-07-12 | IMVT | Salzmann Peter | CEO | S - Sale | $19.73 | -3,233 | 1,231,136 | 0% | -$63,787 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |